Trials / Unknown
UnknownNCT03576456
Sedative Premedication in Coronary Angiography
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 264 (estimated)
- Sponsor
- Universitair Ziekenhuis Brussel · Academic / Other
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
Evaluation of the possible positive effect of sedative premedication prior to coronary angiography in regards to pain and anxiety.
Detailed description
Coronary angiography is an invasive procedure that can cause patient discomfort. Sedative premedication before coronary angiography could be used to reduce anxiety and pain, but evidence is lacking. Previous trials were predominantly conducted in men and in coronary interventions with femoral access. Recently, radial access has become the preferred route for performing coronary angiograms (RIVAL trial) In this setting, sedative premedication could be of interest to reduce radial spasms, patient anxiety and pain.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Alprazolam 0.5 mg | receive alprazolam prior to angio |
| DRUG | Placebo Oral Tablet | receive placebo prior to angio |
Timeline
- Start date
- 2019-01-01
- Primary completion
- 2020-01-01
- Completion
- 2020-08-01
- First posted
- 2018-07-03
- Last updated
- 2018-10-12
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT03576456. Inclusion in this directory is not an endorsement.